Tiburio Therapeutics Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
9
- Latest Deal Type
-
Out of Business
Tiburio Therapeutics General Information
Description
Provider of novel treatments designed to treat rare neuroendocrine tumors and rare endocrine diseases. The company's clinical stage compounds aids to treat non-functioning pituitary adenoma using a dopamine-somatostatin chimeric molecule that has the potential to shrink or halt tumor growth, enabling patients to get effective treatment where there is significant patient need.
Contact Information
Website
www.tiburio.comCorporate Office
- 700 Technology Square
- 2nd Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 700 Technology Square
- 2nd Floor
- Cambridge, MA 02139
- United States
Tiburio Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 27-Apr-2021 | Completed | Out of Business | |||
| 1. Early Stage VC (Series A) | 03-Jan-2019 | Completed | Startup |
Tiburio Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Tiburio Therapeutics Comparisons
Industry
Financing
Details
Tiburio Therapeutics Competitors (77)
One of Tiburio Therapeutics’s 77 competitors is Iconic Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Iconic Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Metabolic Solutions Development Company | Venture Capital-Backed | Kalamazoo, MI | ||||
| Filana Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Astrocyte Pharma | Venture Capital-Backed | Groton, CT | ||||
| Lucid Psycheceuticals | Corporate Backed or Acquired | Toronto, Canada |
Tiburio Therapeutics Patents
Tiburio Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202105915-D0 | Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof | Inactive | 04-Oct-2019 | ||
| GB-2590341-A | Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof | Inactive | 04-Oct-2019 | ||
| WO-2021067897-A1 | Storage stable somatostatin-dopamine chimeric compounds and salt forms thereof | Inactive | 04-Oct-2019 | A61K38/31 |
Tiburio Therapeutics Signals
Tiburio Therapeutics FAQs
-
When was Tiburio Therapeutics founded?
Tiburio Therapeutics was founded in 2019.
-
Where is Tiburio Therapeutics headquartered?
Tiburio Therapeutics is headquartered in Cambridge, MA.
-
What is the size of Tiburio Therapeutics?
Tiburio Therapeutics has 9 total employees.
-
What industry is Tiburio Therapeutics in?
Tiburio Therapeutics’s primary industry is Biotechnology.
-
Is Tiburio Therapeutics a private or public company?
Tiburio Therapeutics is a Private company.
-
What is Tiburio Therapeutics’s current revenue?
The current revenue for Tiburio Therapeutics is .
-
How much funding has Tiburio Therapeutics raised over time?
Tiburio Therapeutics has raised $31M.
-
Who are Tiburio Therapeutics’s competitors?
Iconic Therapeutics, Metabolic Solutions Development Company, Filana Therapeutics, Astrocyte Pharma, and Lucid Psycheceuticals are some of the 77 competitors of Tiburio Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process